PL04.07 FURTHER: A Global, Randomized Study of Firmonertinib at Two Dose Levels in TKI-Naive, Advanced NSCLC with EGFR PACC Mutations

X. Le, Yu Yang, Y. Zhao, D. Planchard, Y. Cheng, X. Li, S. Gadgeel, J. Zhang, A. Spira, H. Hayashi, Jonathan W. Riess, Satoru Kitazono, N. Leighl, B. Gao, Óscar Juan, A.J. de Langen, Julien Mazières, M. Pérol, Yong Jiang, Tao Hu, Jian‐An Huang, Nicola Baio, L. Musib, M. Kowanetz, Song Wang, Wing Leung, Steven Yea, John Hsu, J. Wang